These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 6156641

  • 21. [Biological activity of a new Soviet natural inducer, double-stranded RNA].
    Fomina AN, Grigorian SS, Zaĭtseva OV, Nikolaeva OV, Bukata LA.
    Antibiotiki; 1980 Jan; 25(1):28-32. PubMed ID: 6243898
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Enhancement of interferon antiviral action in L-cells by cyclic nucleotides.
    Allen LB, Eagle NC, Huffman JH, Shuman DA, Meyer RB, Sidwell RW.
    Proc Soc Exp Biol Med; 1974 Jun; 146(2):580-4. PubMed ID: 4365315
    [No Abstract] [Full Text] [Related]

  • 25. The role of cell membrane in the antiviral effect of interferon.
    Pitha PM, Vengris VE, Reynolds FH.
    J Supramol Struct; 1976 Jun; 4(4):467-73. PubMed ID: 778494
    [Abstract] [Full Text] [Related]

  • 26. Interferon induced by endotoxin and Newcastle disease virus in rabbit macrophage and kidney cell cultures.
    Smith TJ, Lubiniecki AS, Armstron JA, Russ SB.
    Proc Soc Exp Biol Med; 1973 Feb; 142(2):481-6. PubMed ID: 4347609
    [No Abstract] [Full Text] [Related]

  • 27. Cyclic AMP potentiation of interferon antiviral activity and effect of interferon on cellular cyclic AMP levels.
    Weber JM, Stewart RB.
    J Gen Virol; 1975 Sep; 28(3):363-72. PubMed ID: 170377
    [Abstract] [Full Text] [Related]

  • 28. [Interferonogenic properties of prodigiozan and its effectiveness in treating acute respiratory diseases in children].
    Povolotskiĭ IaL, Andrushchuk AA, Korzhenevskiĭ AF, Krivokhatskaia LD.
    Antibiotiki; 1980 Jul; 25(7):531-4. PubMed ID: 6157358
    [Abstract] [Full Text] [Related]

  • 29. Rapid onset of the interferon-induced antiviral state in human nasal epithelial and foreskin fibroblast cells.
    Harmon MW, Greenberg SB, Johnson PE.
    Proc Soc Exp Biol Med; 1980 Jun; 164(2):146-52. PubMed ID: 6156464
    [No Abstract] [Full Text] [Related]

  • 30. [Antiviral action of swine leukocyte interferon in mouse experiments].
    Lavrukhina LA, Gutman NR, Manakhova LS.
    Vopr Virusol; 1981 Jun; (4):414-8. PubMed ID: 6171098
    [Abstract] [Full Text] [Related]

  • 31. Influence of acute and chronic ethanol treatment on interferon production in mice.
    Daniluk J, Kandefer-Szerszeń M.
    Arch Immunol Ther Exp (Warsz); 1994 Jun; 42(3):239-46. PubMed ID: 7487360
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of vesicular stomatitis virus replication by epidermal growth factor in human epidermoid A-431 cells.
    Korutla L, Kumar R.
    Biochem Biophys Res Commun; 1996 Mar 27; 220(3):670-4. PubMed ID: 8607823
    [Abstract] [Full Text] [Related]

  • 33. [Production of inhibitors of interferon action by cell lines sensitive and insensitive to the antiviral action of interferon].
    Khesin IaE, Parfenov VV, Amchenkova AM, Narovlianskiĭ AN, Tkach TA.
    Vopr Virusol; 1985 Mar 27; 30(5):584-6. PubMed ID: 2416134
    [Abstract] [Full Text] [Related]

  • 34. Interferon production on mouse fibroblasts induced by various viruses.
    Pugliese A, Cortese D.
    Boll Ist Sieroter Milan; 1980 Mar 31; 59(1):1-3. PubMed ID: 6161620
    [Abstract] [Full Text] [Related]

  • 35. [Effect of natural and recombinant interferons on the development of an antiviral state and on the activity of natural killers].
    Kuznetsov VP, Avdeev GI, Viadro MM, Leĭkin IuD, Frolova IS.
    Dokl Akad Nauk SSSR; 1985 Mar 31; 284(6):1514-6. PubMed ID: 3002740
    [No Abstract] [Full Text] [Related]

  • 36. Morphological and biochemical characterization of vesicular stomatitis virus with low infectivity released from interferon treated cells.
    Maheshwari RK, Friedman RM.
    Uttar Pradesh State Dent J; 1980 Jul 31; 11(3):95-110. PubMed ID: 6159713
    [No Abstract] [Full Text] [Related]

  • 37. [Effect of exogenous interferon on virus-specific immune cytolysis].
    Ovsiannikova NV, Karmysheva VIa.
    Vopr Virusol; 1980 Jul 31; (1):72-6. PubMed ID: 6158178
    [Abstract] [Full Text] [Related]

  • 38. Functional significance of globotriaosyl ceramide in interferon-alpha(2)/type 1 interferon receptor-mediated antiviral activity.
    Khine AA, Lingwood CA.
    J Cell Physiol; 2000 Jan 31; 182(1):97-108. PubMed ID: 10567921
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Transformation by adenovirus type 12 of rat embryol fibroblasts cultivated in the presence of interferon.
    Danielescu G, Anton D, Athanasiu P, Aderca I.
    Rev Roum Virol (1972); 1974 Jan 31; 11(2):133-40. PubMed ID: 4366216
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.